
Christie M. Ballantyne, MD
Advertisement
Articles by Christie M. Ballantyne, MD
Advertisement
Latest Updated Articles
Surrogate Endpoints and Newer Risk Markers in Atherosclerosis ManagementPublished: May 1st 2001 | Updated:
Safety and Tolerability of Lipid-Lowering Drugs After Heart Transplantation: The Heart Transplant Lipid RegistryPublished: March 1st 1997 | Updated:
Treating Hyperlipidemia to Prevent Coronary Heart Disease: What Are the Treatment Goals and How Do We Get There?Published: September 1st 1997 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5



